[Possibilities of neurotrophic therapy in early recovery after stroke].

Abstract

The high prevalence and disability of patients with ischemic stroke make the further development of the rehabilitation system relevant. The implementation of neuroplasticity mechanisms is largely provided by neurotrophic factors. One of the most well-known neurotrophic drugs is cerebrolysin, the efficacy of which in patients with stroke has been confirmed in many clinical studies. A recent meta-analysis included 9 randomized, double-blind, placebo-controlled clinical studies of using cerebrolysin in 1879 patients with hemispheric ischemic stroke, where it was administered at a dose of 30-50 ml for at least 1 week (10-21 days) and therapy was started during 72 hours after stroke. Cerebrolysin has been shown to give patients a 60% chance of better outcomes after a stroke, improves early recovery and increases the likelihood of better recovery.

• Authors: A N Bogolepova
• Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (Zh Nevrol Psikhiatr Im S S Korsakova) Vol. 119 Issue 8. Vyp. 2 Pg. 84-89 ( 2019) ISSN: 1997-7298 [Print] Russia (Federation)
• Vernacular Title: Vozmozhnosti neĭrotroficheskoĭ terapii v rannem vosstanovlenii posle insul'ta.
• PMID: 31825367 (Publication Type: Journal Article)

Chemical References

• Neuroprotective Agents

Topics

• Brain Ischemia (drug therapy)
• Double-Blind Method
• Humans
• Neuroprotective Agents (therapeutic use)
• Randomized Controlled Trials as Topic
• Stroke (drug therapy)
• Treatment Outcome